Colchi(seen) to Reduce Cardiovascular Risk in Established ASCVD
Listen now
Description
Maggie Ruschmeyer, PharmD reviews the evidence in colchicine for secondary prevention of ASCVD. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes. You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 
More Episodes
Megan Edwards, PharmD discusses optimal management of acetaminophen overdose.   For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.  You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on...
Published 11/13/24
Micaela Warfield, PharmD shares updates on the timing of anticoagulation following stroke secondary to atrial fibrillation.   For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes.  You can also connect with the Mayo Clinic’s School of Continuous Professional...
Published 11/06/24